Growing community of inventors

Wiesbaden, Germany

Yves Hüsemann

Average Co-Inventor Count = 7.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 13

Yves HüsemannUgur Sahin (5 patents)Yves HüsemannSebastian Kreiter (5 patents)Yves HüsemannHeinrich Haas (5 patents)Yves HüsemannMustafa Diken (5 patents)Yves HüsemannHossam Hefesha (4 patents)Yves HüsemannKerstin Reuter (3 patents)Yves HüsemannKerstin Walzer (2 patents)Yves HüsemannHossam Hefresha (1 patent)Yves HüsemannYves Hüsemann (5 patents)Ugur SahinUgur Sahin (182 patents)Sebastian KreiterSebastian Kreiter (23 patents)Heinrich HaasHeinrich Haas (20 patents)Mustafa DikenMustafa Diken (17 patents)Hossam HefeshaHossam Hefesha (4 patents)Kerstin ReuterKerstin Reuter (5 patents)Kerstin WalzerKerstin Walzer (7 patents)Hossam HefreshaHossam Hefresha (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Biontech Rna Pharmaceuticals Gmbh (3 from 17 patents)

2. Tron-translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-universitat Mainz (3 from 14 patents)

3. Biontech Se (2 from 66 patents)

4. Tron (1 from 1 patent)

5. Tron—translationale Onkologie an Der Universitatsmedizin Der Johannes Gutenberg-universitat Mainz Gemeinnuzige Gmbh (1 from 1 patent)

6. Tron—translationale Onkologie an Der Universitátsmedizin Der Johannes Gutenberg—universität Mainz Gemeinnützige Gmbh (23 patents)


5 patents:

1. 11660338 - Particles comprising a shell with RNA

2. 11337922 - Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell

3. 11045418 - Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell

4. 10576146 - Particles comprising a shell with RNA

5. 9950065 - Particles comprising a shell with RNA

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/3/2026
Loading…